Diabetes Mellitus and Associated Hypertension, Vascular Disease, and Nephropathy
- 1 December 1995
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 26 (6) , 869-879
- https://doi.org/10.1161/01.hyp.26.6.869
Abstract
Because considerable important information has been published since our previous review, this update concentrates on new findings with regard to cardiovascular and renal risk factors contributing to the striking morbidity and mortality of these coexisting diseases. For example, a large body of investigative data has recently emerged suggesting or delineating a pathogenic role for hyperglycemic-related glycosylation and oxidation of lipoproteins and vascular and renal tissues. Great strides have recently been made in the understanding of platelet, coagulation, lipoprotein, and endothelial abnormalities in the pathogenesis of cardiovascular and renal disease associated with diabetes mellitus and hypertension. Major progress has been made in clarifying the pathophysiology of glomerulosclerosis and other processes involved in the progression of diabetic nephropathy. Furthermore, accumulating data surveyed in this review address new and promising pharmacological interventions that specifically address these pathophysiological mechanisms.Keywords
This publication has 54 references indexed in Scilit:
- Microalbuminuria Precedes the Development of NIDDMDiabetes, 1994
- Diabetes mellitus: A disease of abnormal cellular calcium metabolism?The American Journal of Medicine, 1994
- National High Blood Pressure Education Program Working Group report on hypertension in diabetes.Hypertension, 1994
- Effects of weight reduction on cellular cation metabolism and vascular resistance.Hypertension, 1993
- Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitusThrombosis Research, 1992
- Intracellular Free Magnesium Deficiency Plays a Key Role in Increased Platelet Reactivity in Type II Diabetes MellitusDiabetes Care, 1992
- Diabetes mellitus and hypertension.Hypertension, 1992
- Activation of Coagulation in Diabetes Mellitus in Relation to the Presence of Vascular ComplicationsDiabetic Medicine, 1991
- Elevated fibrinogen and plasminogen activator inhibitor (PAI‐1) in hypertension are related to metabolic risk factors for cardiovascular diseaseJournal of Internal Medicine, 1990
- Abnormalities of platelet function in hypertension and diabetes.Hypertension, 1985